14-3-3 proteins protect AMPK-phosphorylated ten-eleven translocation-2 (TET2) from PP2A-mediated dephosphorylation

Ten-eleven translocation-2 (TET2) is a member of the methylcytosine dioxygenase family of enzymes and has been implicated in cancer and aging because of its role as a global epigenetic modifier. TET2 has a large N-terminal domain and a catalytic C-terminal region. Previous reports have demonstrated that the TET2 catalytic domain remains active independently of the N-terminal domain. As such, the function of the N terminus of this large protein remains poorly characterized. Here, using yeast two-hybrid screening, co-immunoprecipitation, and several biochemical assays, we found that several isoforms of the 14-3-3 family of proteins bind TET2. 14-3-3 proteins bound TET2 when it was phosphorylated at Ser-99. In particular, we observed that AMP-activated protein kinase–mediated phosphorylation at Ser-99 promotes TET2 stability and increases global DNA 5-hydroxymethylcytosine levels. The interaction of 14-3-3 proteins with TET2 protected the Ser-99 phosphorylation, and disruption of this interaction both reduced TET2 phosphorylation and decreased TET2 stability. Furthermore, we noted that protein phosphatase 2A can interact with TET2 and dephosphorylate Ser-99. Collectively, these results provide detailed insights into the role of the TET2 N-terminal domain in TET2 regulation. Moreover, they reveal the dynamic nature of TET2 protein regulation that could have therapeutic implications for disease states resulting from reduced TET2 levels or activity.

[1]  J. Cheville,et al.  Ascorbic acid–induced TET activation mitigates adverse hydroxymethylcytosine loss in renal cell carcinoma , 2019, The Journal of clinical investigation.

[2]  Zhongming Zhao,et al.  TET2 stabilization by 14-3-3 binding to the phosphorylated Serine 99 is deregulated by mutations in cancer , 2019, Cell Research.

[3]  Fei Lan,et al.  Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer , 2018, Nature.

[4]  Yuanyuan Zhou,et al.  Restoration of 5‐hydroxymethylcytosine by ascorbate blocks kidney tumour growth , 2018, EMBO reports.

[5]  O. Abdel-Wahab,et al.  Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression , 2017, Cell.

[6]  Yi Zhang,et al.  TET-mediated active DNA demethylation: mechanism, function and beyond , 2017, Nature Reviews Genetics.

[7]  Wenbing Xie,et al.  Acetylation Enhances TET2 Function in Protecting against Abnormal DNA Methylation during Oxidative Stress. , 2017, Molecular cell.

[8]  S. Chanock,et al.  TET2 binds the androgen receptor and loss is associated with prostate cancer , 2016, Oncogene.

[9]  G. Barton,et al.  14-3-3-Pred: improved methods to predict 14-3-3-binding phosphopeptides , 2015, Bioinform..

[10]  J. Nickels,et al.  Inhibition of AMP Kinase by the Protein Phosphatase 2A Heterotrimer, PP2APpp2r2d* , 2015, The Journal of Biological Chemistry.

[11]  Yi Zhang,et al.  Regulation of TET protein stability by calpains. , 2014, Cell reports.

[12]  Ze Li,et al.  Crystal Structure of TET2-DNA Complex: Insight into TET-Mediated 5mC Oxidation , 2013, Cell.

[13]  S. Batra,et al.  Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer. , 2013, Cancer letters.

[14]  M. Skwarczynska,et al.  Activation of NF-κB signalling by fusicoccin-induced dimerization , 2012, Proceedings of the National Academy of Sciences.

[15]  J. Soulier,et al.  Mutation in TET2 in myeloid cancers. , 2009, The New England journal of medicine.

[16]  C. Cheng,et al.  14-3-3 and its binding partners are regulators of protein-protein interactions during spermatogenesis. , 2009, The Journal of endocrinology.

[17]  A. Hagemeijer,et al.  Acquired mutations in TET2 are common in myelodysplastic syndromes , 2009, Nature Genetics.

[18]  K. Pfizenmaier,et al.  Phospho-specific binding of 14-3-3 proteins to phosphatidylinositol 4-kinase III β protects from dephosphorylation and stabilizes lipid kinase activity , 2006, Journal of Cell Science.

[19]  Michael D. George,et al.  Cyclin E both regulates and is regulated by calpain 2, a protease associated with metastatic breast cancer phenotype. , 2005, Cancer research.

[20]  C. MacKintosh,et al.  Dynamic interactions between 14-3-3 proteins and phosphoproteins regulate diverse cellular processes. , 2004, The Biochemical journal.

[21]  Michael Levin,et al.  Fusicoccin signaling reveals 14-3-3 protein function as a novel step in left-right patterning during amphibian embryogenesis , 2003, Development.

[22]  Michael B. Yaffe,et al.  14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport , 2002, The Journal of cell biology.

[23]  S. Masters,et al.  14-3-3 Proteins Mediate an Essential Anti-apoptotic Signal* , 2001, The Journal of Biological Chemistry.

[24]  E Ruoslahti,et al.  Isolation of high-affinity peptide antagonists of 14-3-3 proteins by phage display. , 1999, Biochemistry.

[25]  James M. Roberts,et al.  Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. , 1996, Genes & development.

[26]  P. Allen,et al.  Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine , 1996, Cell.